[go: up one dir, main page]

AR036324A1 - Polimorfos de zaleplon y metodos para la preparacion de los mismos - Google Patents

Polimorfos de zaleplon y metodos para la preparacion de los mismos

Info

Publication number
AR036324A1
AR036324A1 ARP010103740A ARP010103740A AR036324A1 AR 036324 A1 AR036324 A1 AR 036324A1 AR P010103740 A ARP010103740 A AR P010103740A AR P010103740 A ARP010103740 A AR P010103740A AR 036324 A1 AR036324 A1 AR 036324A1
Authority
AR
Argentina
Prior art keywords
zaleplon
methods
polymorphes
preparation
same
Prior art date
Application number
ARP010103740A
Other languages
English (en)
Inventor
Farhan Aslam
Brett Cowans
Stephen R Byrn
Patrick G Stahly
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR036324A1 publication Critical patent/AR036324A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente se relaciona con formas polimórficas cristalinas del zaleplon N-[3-(3-cianopirazolo [1,5] pirimidin-7-il) fenil]-N-etilacetamida, métodos para la preparación de los mismos, y su uso como ansiolíticos, anti-epilépticos, agentes hipnóticos sedantes y relajantes del músculo esquelético.
ARP010103740A 2000-08-03 2001-08-03 Polimorfos de zaleplon y metodos para la preparacion de los mismos AR036324A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22278500P 2000-08-03 2000-08-03

Publications (1)

Publication Number Publication Date
AR036324A1 true AR036324A1 (es) 2004-09-01

Family

ID=22833666

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010103740A AR036324A1 (es) 2000-08-03 2001-08-03 Polimorfos de zaleplon y metodos para la preparacion de los mismos

Country Status (18)

Country Link
US (2) US20020072527A1 (es)
EP (1) EP1305315A2 (es)
JP (1) JP2004505979A (es)
KR (2) KR20030036659A (es)
CN (2) CN1610682A (es)
AR (1) AR036324A1 (es)
AU (2) AU8311901A (es)
BR (1) BR0113244A (es)
CA (1) CA2417875C (es)
HU (1) HUP0303055A3 (es)
IL (1) IL154088A0 (es)
MX (1) MXPA03001048A (es)
NO (1) NO20030523L (es)
NZ (1) NZ527455A (es)
PL (1) PL365678A1 (es)
SG (1) SG125971A1 (es)
WO (1) WO2002012244A2 (es)
ZA (1) ZA200300779B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1406871A4 (en) * 2001-06-12 2005-01-26 Biogal Gyogyszergyar PROCESS FOR THE PRODUCTION OF N- 3- (3-CYANOPYRAZOLO 1,5-A] PYRIMIDINE-7-YLE) PHENYL] -N-ETHYLACETAMIDE (ZALEPLON)
US20050032818A1 (en) * 2001-06-12 2005-02-10 Entire Interest N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-5-yl)phenyl]-N-ethylacetamide and crystalline forms of zaleplon
WO2003011228A2 (en) * 2001-08-01 2003-02-13 Biogal Gyogyszergyar Rt Purification and crystalline forms of zaleplon
WO2003068238A1 (en) * 2002-02-15 2003-08-21 Biogal Gyogyszergyar Rt. Powder composition comprising zaleplon of defined particle size distribution and pharmaceutical products made therefrom
AU2002343201A1 (en) * 2002-10-16 2004-05-04 Sanmar Speciality Chemicals Limited Synthesis of zaleplon
US7772394B2 (en) 2003-09-04 2010-08-10 Cipla Limited Zaleplon synthesis
US20070098788A1 (en) * 2005-10-28 2007-05-03 Gore Subhash P Non-benzodiazepine hypnotic compositions
EP1956021A1 (en) * 2006-10-11 2008-08-13 Ferrer Internacional, S.A. Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound
US20100196286A1 (en) * 2008-12-01 2010-08-05 Armer Thomas A Inhalation delivery methods and devices
US8555875B2 (en) 2008-12-23 2013-10-15 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
CN102816163A (zh) * 2012-08-20 2012-12-12 四川禾邦阳光制药股份有限公司 扎来普隆的新晶型及制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626538A (en) * 1983-06-23 1986-12-02 American Cyanamid Company [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
KR0167261B1 (ko) * 1995-10-19 1999-04-15 문정환 전원공급 제어회로
US5714607A (en) * 1995-12-01 1998-02-03 American Cyanamid Company Process improvement in the synthesis of N- 3-(3-cyano-pyrazolo 1,5-a!pyrimidin-7-yl)phenyl!-N-ethylacetamide
AR029780A1 (es) * 2000-12-13 2003-07-16 Gador Sa Procedimiento mejorado para la obtencion de n-[3(3-ciano-pirazolo[1,5-a]pirimidin-7-il)fenil]-n-etil-acetamida
WO2003011228A2 (en) * 2001-08-01 2003-02-13 Biogal Gyogyszergyar Rt Purification and crystalline forms of zaleplon

Also Published As

Publication number Publication date
IL154088A0 (en) 2003-07-31
CN1610682A (zh) 2005-04-27
KR20030036659A (ko) 2003-05-09
US20050176735A1 (en) 2005-08-11
KR20070086867A (ko) 2007-08-27
HUP0303055A3 (en) 2004-11-29
MXPA03001048A (es) 2004-02-26
AU8311901A (en) 2002-02-18
CA2417875A1 (en) 2002-02-14
ZA200300779B (en) 2003-08-22
CN1847244A (zh) 2006-10-18
JP2004505979A (ja) 2004-02-26
AU2001283119B2 (en) 2007-11-15
NO20030523L (no) 2003-03-11
NZ527455A (en) 2005-07-29
NO20030523D0 (no) 2003-02-03
BR0113244A (pt) 2003-07-08
CA2417875C (en) 2008-12-09
EP1305315A2 (en) 2003-05-02
PL365678A1 (en) 2005-01-10
HUP0303055A2 (hu) 2004-01-28
WO2002012244A3 (en) 2002-06-13
US20020072527A1 (en) 2002-06-13
WO2002012244A2 (en) 2002-02-14
SG125971A1 (en) 2006-10-30

Similar Documents

Publication Publication Date Title
AR036324A1 (es) Polimorfos de zaleplon y metodos para la preparacion de los mismos
TR200000197T2 (tr) Yeni bileşimler
PA8637601A1 (es) Compuestos moduladores de la actividad de c-kit y usos de los mismos
BR0107403A (pt) Compostos de n-(5,7-dimetóxi[1,2,4] triazolo[1,5-alfa]pirimidin-2-il)arilsulfonamida e o uso dos mesmos como herbicidas
TR200000151T2 (tr) Yeni bileşimler.
EE05222B1 (et) Triasolo(4,5-d)primidiinihendi kristalne ja amorfne vorm, meetod selle valmistamiseks ning kasutamine
BR0313695A (pt) Polimorfo de n-metil-n-(3-{3-[2-tienil carbonil]pirazol-[1,5-alfa]pirimidin-7-il}fenil) acetamida e composições e processos relacionados ao mesmo
HN2001000040A (es) LAS 5-ALQUILPIRIDO [2,3-d] PIRIMIDINAS SON INHIBIDORAS DE LAS CINASAS DE TIROSINA Y QUE DEPENDEN DE LA CICLINA SOLICITANTE: WARNER LAMBER COMPANY PAIS: ESTADOS UNIDOS DE AMERICA.
AR023727A1 (es) Compuestos empleados en el tratamiento de padecimientos inflamatorios
BR0108715A (pt) Compostos de 3,4-diidro-1h-pirimido[4,5-d]-pirimidin-2-ona 1,5-dissubstituìdos e seu uso no tratamento de doenças mediadas pela cinase csbp/p38
AR026187A1 (es) Heterociclos de nitrogeno biciclicos alquilamino substituidos
AR026275A1 (es) Compuestos farmaceuticos
HN1999000146A (es) Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas.
ECSP034924A (es) Derivados sustituidos del 1-oxa-2,8-daza-espiro[4,5]dec-2-eno
ECSP055609A (es) "Uso de inhibidores de la IkB-quinasa para el tratamiento del dolor"
TR200002380T2 (tr) Yeni triazolo (4,5-d) pirimidin bileşikleri
MX9305833A (es) Procedimiento para la preparacion de pirrolo[2,3-d]pirimidinas 5-sustituidas.
SE9702563D0 (sv) Compounds
PL374176A1 (en) Process for purifying n-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide(zaleplon) and crystalline forms of zaleplon accessible with the process
ES533654A0 (es) Procedimiento para preparar pirazol (1,5-a)pirimidin-metanonas
DE69911785D1 (de) Triazolo[4,5-d]pyrimidin-verbindungen
EP4282868A4 (en) SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINE-7-AMINE DERIVATIVE, AND COMPOSITIONS AND MEDICAL USE THEREOF
DE69927251D1 (de) Verfahren zur herstellung von purinderivaten und dessen zwischenprodukte
ES2166026T3 (es) Derivados de 1,2,3-benzotiadiazol y su uso como microbicidas.
EA200200320A1 (ru) ПОЛИМОРФЫ N-МЕТИЛ-N-(3-{3-[2-ТИЕНИЛКАРБОНИЛ]ПИРАЗОЛ[1,5-α]ПИРИМИДИН-7-ИЛ}ФЕНИЛ)АЦЕТАМИДА И ОТНОСЯЩИЕСЯ К НИМ КОМПОЗИЦИИ И СПОСОБЫ

Legal Events

Date Code Title Description
FB Suspension of granting procedure